Procter & Gamble Company (The) $PG Stock: Alta Advisers Ltd Raises Position

Key Points

• Alta Advisers increased its Procter & Gamble stake by 86% in the third quarter, ending the period with 16,400 shares valued at about $2.38 million. Institutional investors overall own 65.77% of the stock.
• P&G beat quarterly earnings and revenue estimates, reporting $2.00 per share and $23.28 billion in revenue, up 4% year over year. The company declared a quarterly dividend of $1.0885 per share, equivalent to a 2.6% yield.
• Company insiders have been selling shares: insiders sold 161,709 shares worth about $26.2 million over the past 90 days, including sales by the CEO and another executive.

Alta Advisers Ltd raised its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 86.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,400 shares of the company's stock after purchasing an additional 7,582 shares during the period. Alta Advisers Ltd's holdings in Procter & Gamble were worth $2,383,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. purchased a new position in Procter & Gamble in the 2nd quarter valued at $27,862,105,000. Bank of America Corp DE purchased a new stake in shares of Procter & Gamble during the second quarter worth $3,850,628,000. Bank of New York Mellon Corp purchased a new stake in shares of Procter & Gamble during the second quarter worth $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Procter & Gamble during the second quarter worth $1,480,650,000. Finally, Corient Private Wealth LP acquired a new stake in shares of Procter & Gamble in the second quarter valued at about $335,908,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Procter & Gamble news, CEO Sundar G. Raman sold 38,253 shares of the stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $165.00, for a total transaction of $6,311,745.00. Following the completion of the transaction, the chief executive officer owned 47,745 shares of the company's stock, valued at $7,877,925. This trade represents a 44.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Victor Aguilar sold 18,812 shares of the stock in a transaction dated Friday, October 30th. The stock was sold at an average price of $164.43, for a total transaction of $3,093,257.16. Following the transaction, the insider directly owned 55,243 shares of the company's stock, valued at approximately $9,083,606.49. This trade represents a 25.40% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 161,709 shares of company stock worth $26,244,058. 0.23% of the stock is currently owned by corporate insiders.

Procter & Gamble Trading Down 0.1%

Shares of PG opened at $167.15 on Friday. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $170.52. The firm has a 50-day moving average price of $151.56 and a 200 day moving average price of $149.34. The firm has a market capitalization of $387.41 billion, a P/E ratio of 25.17, a P/E/G ratio of 4.11 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping analysts' consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The company had revenue of $23.28 billion for the quarter, compared to the consensus estimate of $22.80 billion. During the same period in the previous year, the firm earned $1.99 earnings per share. Procter & Gamble's quarterly revenue was up 4.0% compared to the same quarter last year. Sell-side analysts forecast that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble's dividend payout ratio (DPR) is presently 65.51%.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G recently reached a 52-week high as investors favored reliable dividend-paying consumer-staples companies amid political uncertainty. Its latest reported quarter also beat earnings and revenue estimates, with sales up 4% year over year. Article: Dividend stocks reach highs
• Neutral Sentiment: P&G will webcast its November 19 Investor Day, where its leadership team plans to discuss strategy and the company’s long-term transformation. Investors may look for details on growth plans and execution. Article: Investor Day webcast
• Neutral Sentiment: Bernstein maintained a Hold rating on PG, suggesting a cautious view rather than a clear near-term catalyst. Article: Bernstein rating
• Negative Sentiment: CFO Andre Schulten sold 33,624 shares, reducing his direct holding by about 34%. Insider sales can weigh on sentiment, although they do not necessarily signal a change in the company’s outlook. Article: CFO share sale
• Negative Sentiment: A comparison of P&G and Colgate-Palmolive flagged rising oil prices and cautious U.S. shoppers as challenges for margins. The report says the companies’ margins are moving in opposite directions but does not specify which direction applies to P&G. Article: P&G and Colgate-Palmolive comparison

Analyst Ratings Changes

PG has been the topic of several research reports. TD Cowen raised their price target on shares of Procter & Gamble from $150.00 to $166.00 and gave the stock a "hold" rating in a research note on Friday, October 23rd. Evercore raised shares of Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 price objective for the company in a research note on Tuesday, October 6th. Royal Bank Of Canada set a $169.00 price objective on shares of Procter & Gamble in a report on Friday, October 23rd. Freedom Broker raised shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $176.00 target price on the stock in a research note on Friday, October 23rd. Finally, Piper Sandler boosted their target price on Procter & Gamble from $145.00 to $167.00 and gave the stock a "neutral" rating in a report on Monday, October 26th. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $170.57.

About Procter & Gamble

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.